|
1
|
Xi Y and Xu P: Global colorectal cancer
burden in 2020 and projections to 2040. Transl Oncol.
14(101174)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Espinosa-Tamez P, Suazo-Zepeda E,
Sánchez-Blas H, Meneses-Medina M, Huitzil-Meléndez FD, Van Loon K,
Potter M and Lajous M: National and state-level colorectal cancer
mortality trends in Mexico, 1998-2018. Salud Publica Mex. 64:5–13.
2021.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Li J, Ma X, Chakravarti D, Shalapour S and
DePinho RA: Genetic and biological hallmarks of colorectal cancer.
Genes Dev. 35:787–820. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bhat AA, Nisar S, Singh M, Ashraf B,
Masoodi T, Prasad CP, Sharma A, Maacha S, Karedath T, Hashem S, et
al: Cytokine- and chemokine-induced inflammatory colorectal tumor
microenvironment: Emerging avenue for targeted therapy. Cancer
Commun (Lond). 42:689–715. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang T, Ma C, Zhang Z, Zhang H and Hu H:
NF-κB signaling in inflammation and cancer. MedComm (2020).
2:618–653. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H:
Targeting NF-κB pathway for the therapy of diseases: Mechanism and
clinical study. Signal Transduct Target Ther. 5(209)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mitchell S, Tsui R, Tan ZC, Pack A and
Hoffmann A: The NF-κB multidimer system model: A knowledge base to
explore diverse biological contexts. Sci Signal.
16(eabo2838)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Prescott JA, Mitchell JP and Cook SJ:
Inhibitory feedback control of NF-κB signalling in health and
disease. Biochem J. 478:2619–2664. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bacher S, Meier-Soelch J, Kracht M and
Schmitz ML: Regulation of transcription factor NF-κB in its natural
habitat: The nucleus. Cells. 10(753)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hayden MS and Ghosh S: Regulation of NF-κB
by TNF family cytokines. Semin Immunol. 26:253–266. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Moreno-Lorenzana D, Torres-Barrera P,
Flores-Lopez G, Chávez-González MA, Isordia-Salas I, Yoder MC,
Majluf-Cruz A and Alvarado-Moreno JA: Self-regulation of TNF-α
induces dysfunction of endothelial colony-forming cells from
patients with venous thromboembolic disease. Arch Med Res.
53:680–687. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mattioli I, Sebald A, Bucher C, Charles
RP, Nakano H, Doi T, Kracht M and Schmitz ML: Transient and
selective NF-kappa B p65 serine 536 phosphorylation induced by T
cell costimulation is mediated by I kappa B kinase beta and
controls the kinetics of p65 nuclear import. J Immunol.
172:6336–6344. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tsuchiya R, Tanaka T, Hozumi Y, Nakano T,
Okada M, Topham MK, Iino M and Goto K: Downregulation of
diacylglycerol kinase ζ enhances activation of cytokine-induced
NF-κB signaling pathway. Biochim Biophys Acta. 1853:361–369.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
González-Quezada BA, Santana-Bejarano UF,
Corona-Rivera A, Pimentel-Gutiérrez HJ, Silva-Cruz R,
Ortega-De-la-Torre C, Franco-Topete R, Franco-Topete K,
Centeno-Flores MW, Maciel-Gutiérrez VM, et al: Expression profile
of NF-κB regulated genes in sporadic colorectal cancer patients.
Oncol Lett. 15:7344–7354. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xu H, Liu T, Li J, Chen F, Xu J, Hu L,
Jiang L, Xiang Z, Wang X and Sheng J: Roburic acid targets TNF to
inhibit the NF-κB signaling pathway and suppress human colorectal
cancer cell growth. Front Immunol. 13(853165)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Alotaibi AG, Li JV and Gooderham NJ:
Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype
in colorectal cancer epithelial cells: Mechanistic support for the
role of MicroRNA-21. Cancers (Basel). 15(627)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Patwardhan MB, Samsa GP, McCrory DC,
Fisher DA, Mantyh CR, Morse MA, Prosnitz RG, Cline KE and Gray RN:
Cancer care quality measures: Diagnosis and treatment of colorectal
cancer. Evid Rep Technol Assess. (Full Rep):1–116. 2006.PubMed/NCBI
|
|
20
|
Hawkins AT, Rothman RL, Geiger TM, Canedo
JR, Edwards-Hollingsworth K, LaNeve DC and Penson DF:
Patient-reported outcome measures in colon and rectal surgery: A
systematic review and quality assessment. Dis Colon Rectum.
63:1156–1167. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ali MY, Anand SV, Tangella K, Ramkumar D
and Saif TA: Isolation of primary human colon tumor cells from
surgical tissues and culturing them directly on soft elastic
substrates for traction cytometry. J Vis Exp.
(e52532)2015.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 4:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu D, Wu P, Zhao L, Huang L, Zhang Z, Zhao
S and Huang J: NF-κB expression and outcomes in solid tumors: A
systematic review and meta-analysis. Medicine (Baltimore).
94(e1687)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Andersen V, Christensen J, Overvad K,
Tjønneland A and Vogel U: Polymorphisms in NFkB, PXR, LXR and risk
of colorectal cancer in a prospective study of Danes. BMC Cancer.
10(484)2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lewander A, Gao J, Adell G, Zhang H and
Sun XF: Expression of NF-κB p65 phosphorylated at serine-536 in
rectal cancer with or without preoperative radiotherapy. Radiol
Oncol. 45:279–284. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kumar A, Singh AK, Singh H, Thareja S and
Kumar P: Regulation of thymidylate synthase: An approach to
overcome 5-FU resistance in colorectal cancer. Med Oncol.
40(3)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Braumüller H, Mauerer B, Andris J, Berlin
C, Wieder T and Kesselring R: The cytokine network in colorectal
cancer: Implications for new treatment strategies. Cells.
12(138)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Borowczak J, Szczerbowski K, Maniewski M,
Kowalewski A, Janiczek-Polewska M, Szylberg A, Marszałek A and
Szylberg Ł: The role of inflammatory cytokines in the pathogenesis
of colorectal carcinoma-recent findings and review. Biomedicines.
10(1670)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jana A, Krett NL, Guzman G, Khalid A,
Ozden O, Staudacher JJ, Bauer J, Baik SH, Carroll T, Yazici C and
Jung B: NFkB is essential for activin-induced colorectal cancer
migration via upregulation of PI3K-MDM2 pathway. Oncotarget.
8:37377–37393. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Berkovich L, Gerber M, Katzav A, Kidron D
and Avital S: NF-kappa B expression in resected specimen of colonic
cancer is higher compared to its expression in inflammatory bowel
diseases and polyps. Sci Rep. 12(16645)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lewander A, Gao J, Carstensen J, Arbman G,
Zhang H and Sun XF: NF-κB p65 phosphorylated at serine-536 is an
independent prognostic factor in Swedish colorectal cancer
patients. Int J Colorectal Dis. 27:447–452. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kojima M, Morisaki T, Sasaki N, Nakano K,
Mibu R, Tanaka M and Katano M: Increased nuclear factor-kB
activation in human colorectal carcinoma and its correlation with
tumor progression. Anticancer Res. 24:675–681. 2004.PubMed/NCBI
|
|
33
|
Berardi R, Maccaroni E, Mandolesi A,
Mantello G, Onofri A, Biscotti T, Pierantoni C, Siquini W,
Marmorale C, Guerrieri M, et al: Nuclear factor-κB predicts outcome
in locally advanced rectal cancer patients receiving neoadjuvant
radio-chemotherapy. Dig Liver Dis. 44:617–622. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Toney NJ, Schlom J and Donahue RN:
Phosphoflow cytometry to assess cytokine signaling pathways in
peripheral immune cells: Potential for inferring immune cell
function and treatment response in patients with solid tumors. J
Exp Clin Cancer Res. 42(247)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bitar M, Boldt A, Freitag MT, Gruhn B,
Köhl U and Sack U: Evaluating STAT5 phosphorylation as a mean to
assess T cell proliferation. Front Immunol. 10(722)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Davies R, Vogelsang P, Jonsson R and Appel
S: An optimized multiplex flow cytometry protocol for the analysis
of intracellular signaling in peripheral blood mononuclear cells. J
Immunol Methods. 436:58–63. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Canto E, Isobe N and Didonna A: MS-EPIC
Study Group. Hauser SL and Oksenberg JR: Aberrant STAT
phosphorylation signaling in peripheral blood mononuclear cells
from multiple sclerosis patients. J Neuroinflammation.
15(72)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Santana-Bejarano UF, Bobadilla-Morales L,
Mendoza-Maldonado L, Torres-Anguiano E, Brukman-Jiménez SA,
Barba-Barba CC, Corona-Rivera JR and Corona-Rivera A: In
vitro effect of curcumin in combination with chemotherapy drugs
in Ph+ acute lymphoblastic leukemia cells. Oncol Lett.
17:5224–5240. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pimentel-Gutiérrez HJ, Bobadilla-Morales
L, Barba-Barba CC, Ortega-De-La-Torre C, Sánchez-Zubieta FA,
Corona-Rivera JR, González-Quezada BA, Armendáriz-Borunda JS,
Silva-Cruz R and Corona-Rivera A: Curcumin potentiates the effect
of chemotherapy against acute lymphoblastic leukemia cells via
downregulation of NF-κB. Oncol Lett. 12:4117–4124. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Bates RC and Mercurio AM: Tumor necrosis
factor-alpha stimulates the epithelial-to-mesenchymal transition of
human colonic organoids. Mol Biol Cell. 14:1790–1800.
2003.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ou B, Zhao J, Guan S, Feng H, Wangpu X,
Zhu C, Zong Y, Ma J, Sun J, Shen X, et al: CCR4 promotes metastasis
via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in
colorectal cancer. Oncotarget. 30:47637–47649. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jovanovic DV, Di Battista JA, Martel J,
Jolicoeur FC, He Y, Zhang M, Mineau F and Pelletier JP: IL-17
stimulates the production and expression of proinflammatory
cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol.
160:3513–3521. 1998.PubMed/NCBI
|
|
43
|
Bausch-Fluck D, Hofmann A, Bock T, Frei
AP, Cerciello F, Jacobs A, Moest H, Omasits U, Gundry RL, Yoon C,
et al: A mass spectrometric-derived cell surface protein atlas.
PLoS One. 10(e0121314)2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Al Obeed OA, Alkhayal KA, Al Sheikh A,
Zubaidi AM, Vaali-Mohammed MA, Boushey R, Mckerrow JH and Abdulla
MH: Increased expression of tumor necrosis factor-α is associated
with advanced colorectal cancer stages. World J Gastroenterol.
20:18390–18396. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Grimm M, Kim M, Rosenwald A, von Raden BH,
Tsaur I, Meier E, Heemann U, Germer CT, Gasser M and Waaga-Gasser
AM: Tumour-mediated TRAIL-receptor expression indicates effective
apoptotic depletion of infiltrating CD8+ immune cells in clinical
colorectal cancer. Eur J Cancer. 46:2314–2323. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Stanilov N, Miteva L, Dobreva Z and
Stanilova S: Colorectal cancer severity and survival in correlation
with tumour necrosis factor-alpha. Biotechnol Biotechnol Equip.
28:911–917. 2014.PubMed/NCBI View Article : Google Scholar
|
